After graduating Drake University with his PharmD/MBA, Scott completed the Visiting Scientist Fellowship at Eli Lilly and Company. During his Fellowship year, he was a Regulatory Reviewer for Advertising and Promotional materials where he worked alongside marketing to ensure marketing material was accurate and non-misleading. Following the Fellowship, he transitioned into Clinical Development as a Clinical Trial Project Manager. In this position, he leads multi-functional study teams through development, execution, and closeout of diabetes studies. Specifically, he focuses on studies involving investigational insulins, investigational insulin pumps, and connected system technology such as Insulin Pen dose capture devices, apps, and cloud data storage and analytics.
